BioSyent Releases Q3 and YTD 2021 Financial Results
November 18, 2021 17:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Nov. 18, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three and nine months ended September 30, 2021. Key...
BioSyent Schedules Q3 and YTD 2021 Earnings Release for November 18, 2021
November 10, 2021 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Nov. 10, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and nine months ended...
BioSyent Announces Launch of New FeraMAX® Pd Powder 15
October 19, 2021 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Oct. 19, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce the launch of FeraMAX® Pd Powder 15 by its subsidiary,...
BioSyent annonce le lancement du nouveau FeraMAX (MD) Pd Poudre 15
October 19, 2021 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, 19 oct. 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (« BioSyent »,« la Société », Bourse de croissance TSX : RX) a le plaisir d’annoncer le lancement de FeraMAXMD Pd Poudre 15 par...
BioSyent Releases Q2 and H1 2021 Financial Results
August 25, 2021 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Aug. 25, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three and six months ended June 30, 2021. Key...
BioSyent Schedules Q2 and H1 2021 Earnings Release for August 25, 2021
August 17, 2021 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Aug. 17, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and six months ended June 30,...
BioSyent Signs Exclusive Technology Agreement
July 13, 2021 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, July 13, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that its subsidiary, BioSyent Pharma Inc., has signed an agreement to...
BioSyent Releases Financial Results for Q1 2021
May 27, 2021 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, May 27, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months ended March 31, 2021. Key highlights...
BioSyent Schedules Q1 2021 Earnings Release for May 27, 2021
May 20, 2021 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, May 20, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2021 on...
FeraMAX(MD) est le 1er choix de supplément de fer recommandé par les pharmaciens et les médecins canadiens pour la sixième année consécutive
May 05, 2021 08:42 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, 05 mai 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (« BioSyent », Bourse de croissance TSX : RX) a le plaisir d’annoncer que pour la sixième année consécutive, FeraMAXMD a été...